Related Experiment Videos
Hypothalamic-pituitary dysfunction in polycystic ovarian disease
1Division of Reproductive Endocrinology, University of Maryland School of Medicine, Baltimore.
Endocrinology and Metabolism Clinics of North America
|December 1, 1988
Summary
Disordered gonadotropin economy is key in Polycystic Ovary Syndrome (PCOS). Altered luteinizing hormone (LH) secretion, influenced by central or peripheral factors, drives ovarian androgen excess.
Area of Science:
- Reproductive Endocrinology
- Neuroendocrinology
- Gynecology
Background:
- Polycystic Ovary Syndrome (PCOS) pathophysiology involves disordered gonadotropin economy.
- The precise mechanisms driving altered gonadotropin release in PCOS are debated.
- Distinguishing between primary central nervous system (CNS) dysfunction and secondary peripheral modulation is challenging.
Purpose of the Study:
- To elucidate the role of gonadotropin economy in PCOS pathophysiology.
- To investigate the origins of altered gonadotropin release in PCOS.
- To understand the contribution of LH hypersecretion and bioactivity to ovarian androgen excess.
Main Methods:
- Review of existing literature on gonadotropin regulation in PCOS.
- Analysis of gonadotropin pulse frequency and amplitude alterations.
- Assessment of LH bioactivity and its impact on ovarian theca cells.
Main Results:
- Gonadotropin release alterations involve both pulse frequency and amplitude, leading to increased LH secretion.
- Hypersecreted and potentially more bioactive LH contributes to intense stimulation of ovarian androgen production.
- Estrogen's role in modulating gonadotropin release is significant, potentially acting at pituitary and CNS levels.
Conclusions:
- Disordered gonadotropin economy, particularly increased LH secretion, is central to PCOS.
- The exact origin of altered gonadotropin release (central vs. peripheral) requires further investigation.
- Estrogen's modulatory effects on gonadotropin release warrant further study at different regulatory levels.